Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening.

Abstract

Patient screening is important for early diagnosis of colorectal cancer (CRC). The present study aimed to compare the multitarget stool DNA (mt-sDNA) test with the fecal occult blood test (FOBT) for CRC screening. A total of 151 individuals were screened using colonoscopy, mt-sDNA and FOBT for the detection of CRC and adenoma. The results of the mt-sDNA test and FOBT were compared with colonoscopy to examine their sensitivity and specificity. Subsequently, the sensitivity and specificity of the mt-sDNA test were compared with those of FOBT in CRC and large adenoma. Stool samples were collected from patients with CRC (n=50) or large adenoma (n=51), as well as from normal controls (n=50). The mt-sDNA test outperformed FOBT in detecting CRC with a sensitivity of 90.0% (45/50) vs. 42.0% (21/50), advanced adenoma with a sensitivity of 70.6% (36/51) vs. 19.6% (10/51), stage I-III CRC with a sensitivity of 91.9% (34/37) vs. 29.7% (11/37), and stage IV CRC with a sensitivity of 84.6% (11/13) vs. 76.9% (10/13). In addition, the mt-sDNA test exhibited a specificity of 94.0% (47/50) in detecting CRC, which was superior to FOBT with a specificity of 90.0% (45/50). Therefore, the mt-sDNA test may have higher sensitivity and specificity compared with FOBT in diagnosing both CRC and advanced adenoma.

• Authors: Cuiping Yang, Wei Wu, Yanping Yang, Xiaojin Yang, Jing Sun, Weiyu Zhang, Kun Liu, Haifeng Ying, Songyao Jiang, Xiaojun Yu, Yiqing Shi, Yufen Zhou, Shiyan Zhu, Ying Xu, Yanfei Ding, Ling Xie, Boer Cai, Xiaorong Xin, Ping Chen, Ren Zhao, Yunlin Wu
• Journal: Oncology letters (Oncol Lett) Vol. 20 Issue 2 Pg. 1193-1200 (Aug 2020) ISSN: 1792-1074 [Print] Greece
• PMID: 32724359 (Publication Type: Journal Article)
• Copyright: Copyright: © Yang et al.